Shira Miasnik | Product & UX


  • products 
    • Amelie
    • PhilNet
    • Monitair
    • Zapp
    • Zapp designers
    • AtHoc
    • Neocraft
    • Para
  • Teaching
  • Contact

AMELIE
Personal medical software
using AI, aimed to diagnose
monogenic diseases


MVp / Product Discovery / Product Design /
recruit & dev management

AMELIE



Role



1st product person



Product Description



AMELIE is a precision medicine technology that provides care givers with personalized and continuous patient diagnosis support. AMELIE utilizes Natural Language Processing of medical knowledgebase of patient's medical record, combined with Machine Learning based analysis of WGS/WES genomic data, to provide continuous personalized diagnosis. AMELIE was developed based on research conducted in the Bejerano Lab at Stanford University's school of Medicine and the Computer Science Department.



Responsibilities



  • Worked closely with the Stanford Bioinformatics Professor who led the science behind AMELIE, and with the business founders, to productize the Stanford based research.
  • Led the frontend design and development, including recruit of development team, definition of product stories, management of QA process till final launch.
  • Defined with the founding team the roadmap for the first design partners pilots, aiming to assess the academic based research in a clinical environment. First pilot aired on the 3rd quarter of 2020.


Step by step



The process of diagnosing the patient's disease is divided and simplified to four steps: Case Info, where a clinician inputs the patient's genomes and his/her medical record. Continuing 'Processing' where AMELIE processes the above information, using a machine learning approach and analyzes an extensive database of scientific literature to find the relevant literature that explains the disease genetic causality, leading to 'Results' where a ranked list of scientific literature relevant to the patient's genetic disease, and finally 'Reanalysis', which is an ongoing analysis of the patient's disease till a resolved diagnosis.



From an unresolved case to a resolved one



Genetic disease diagnosis is a challenging investigation, which in most cases is not concluded in one diagnosis attempt. Most cases require an ongoing continuous analysis of the literature which is being constantly updated by the scientific community, and may surprise with a resolution to an unresolved case. AMELIE enables the first analysis, as well as an automatic continuous analysis of a patient's case.


To start the diagnosis, a clinician inputs the patient's genomes and his/her medical record. AMELIE processes the above information, using a machine learning approach and analyzes an extensive database of scientific literature to find the relevant literature that explains the disease genetic causality.



NLP based medical record analysis



AMELIE analyzes medical notes written as free text by doctors, and extracts automatically from the notes the patient's symptoms ranked by importance. The clinician is presented with the original text and the NLP analysis, with additional metadata that assists the clinician to select the relevant symptoms.



Showcasing one case's causal genes and ranked literature



After AMELIE's processing, the clinician is presented with a list of ranked causal genes of the patient's disease, and associated literature per gene. AMELIE highlights per paper, the clinical symptoms which are an exact match, a missing or an approximate match to the patient's ones. These are amongst the tools to assist clinicians in selecting the most relevant papers that could assist in resolving the case.



Cases Management



First version of AMELIE case management showcases high level details and status per case, as well as allowing access to the full case and export to file of its details. The case management screen allows the configuration of continuous analysis per case.



SHIRA MIASNIK | Product Management & UX Design
שירה מיאסניק | ניהול מוצר ועיצוב חווית משתמשים